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Every so often, a paper comes along that brings clarity to
an issue. Clarity is not necessarily a final resolution, but
rather a conceptual framework for productively address-
ing that issue. Such a paper could be based on a break-
through discovery, an intriguing observation, a flash of in-
tuition, or a systematic analysis. An excellent example of
 
the latter is in this issue of 
 
The Journal of Cell Biology
 
(Hotary et al., 2000). With a deceptively simple experi-
mental layout, Hotary et al. (2000) explore the relative
role of soluble versus membrane-anchored matrix metal-
loproteinases (MMP) in tissue morphogenesis. In their in
vitro morphogenesis and matrix invasion models, the con-
clusion is clear cut: membrane-anchored (MT-MMPs), not
soluble MMPs, effectively regulate cell migration through
extracellular matrix and affect self-organization of cells
into tubular structures (Fig. 1).
Cell migration through the matrix is a key component of
morphogenesis, i.e., how tissue or organs attain their
shape. It is truly an invasive process, whereby cells move
into and possibly colonize new territory, and that is why
one can speak of cell invasion and morphogenesis in the
 
same breath, and test them with the same assay (Hotary
et al., 2000). According to their differentiated type, the mi-
gratory cells may give rise to new structures within the ma-
trix they invaded, e.g., tubules, alveoli, or acini, shaping
tissues and organs. It is evident, then, why we would like to
know the molecular details of migration through the ma-
trix: what motivates cells to migrate, how they do it, how is
the process controlled.
There is general agreement that MMPs are important in
the execution of migration through the matrix and of inva-
 
sion, based on abundant data correlating invasive phenom-
ena with the presence of MMPs (Stetler-Stevenson et al.,
1993; Werb, 1997). In recent years, mainly via isolation of
gelatinolytic activities and homology cloning, the burgeon-
ing protein family of MMPs has come to include, in man,
close to 20 members (Table I). Several of these degrade
collagens (Table I), the most abundant components of the
extracellular matrix, though fine substrate specificity is
still at issue (Koshikawa et al., 2000). The majority of
MMPs are secreted proteins generally requiring activation
for enzymatic activity. A few are true transmembrane pro-
teins, the membrane-type metalloproteinases or MT-
MMPs, which are expressed at the cell surface in activated
form.
Does the MMP structural diversity reflect functional re-
dundancy or specialization? With their systematic expres-
sion of proteinases in select cell types, followed by chal-
lenge of specified complex extracellular matrices, Hotary
et al. (2000) addressed this fundamental question and
came away with an unexpected mechanistic insight (Fig.
1). Key to this accomplishment was their effort to merge
modern trends from the fields of proteinase biochemistry,
cell migration, tumor invasion, and morphogenesis. Such
multidisciplinary approaches often electrify fields and, as
in most cell biology problems today, are badly needed in
MMP research at this junction. For historical reasons, and
because MMPs have been for the most part characterized
in biochemistry laboratories, the emphasis of the field has
been on enzymatic activities, mechanisms of activation, ki-
netics and substrate specificity (Nagase and Woessner,
1999). The combined output of several outstanding groups
has produced an extraordinary in depth understanding of
MMP structure–function relationships, of intricate activa-
tion mechanisms and proteinase interactions with natural
or man made inhibitors, and provided a solid foundation
for MMP enzyme biochemistry (Docherty et al., 1992;
Strongin et al., 1993; Morgunova et al., 1999). In contrast,
the cell biology of MMPs has lagged behind. Targeted
gene disruption by homologous recombination has pro-
duced MMP knockout mouse strains with phenotypes
ranging from the mild to the dramatic (Itoh et al., 1998; Vu
et al., 1998; Holmbeck et al., 1999). Attempts to explain
these phenotypes in molecular terms have further raised
our discomfort for the currently poor understanding of
MMPs in terms of their cell biology. The Hotary et al.
(2000) paper is an important step towards bridging the gap
between enzyme biochemistry and whole organism analy-
ses of MMP phenotypes. Their findings already begin to
make some sense of the fact that soluble MMP knockout
mice present themselves with mild developmental pheno-
types, whereas MT1-MMP knockout mice display severe
abnormalities in bone formation, angiogenesis and col-
lagen turnover, leading to dwarfism, dysmorphic skull, and
precocious death (Holmbeck et al., 1999; Zhou et al.,
2000). Thus, the next wave in this arena should be analyz-
ing the effects of MMPs on cell behavior in complex model
systems, allowing us to dissect the in vivo functions of
MMPs in greater detail.
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Migration through the matrix may be a property also of
neoplastic cells, even though they may have originated
from nonmigratory cells. Contrary to morphogenesis, the
results of neoplastic cell migration are often disastrous: tu-
mor invasion and metastasis set in. Important questions
then arise: do neoplastic cells in fact migrate through the
matrix and ultimately invade tissues by the same mecha-
nisms as normal cells? And, how do they acquire ability to
migrate? A result of Hotary et al. (2000) offers an oppor-
tunity for reflection on possible answers. In their system,
the genesis of tubular structures requires invasion of the
matrix, and MT-MMPs appear critical for this. However,
express too much of them, and the morphogenetic pro-
gram is lost. Rather, nondescript matrix invasion takes
place (Fig. 1). This result suggests that intriguingly simple
rules may determine whether matrix invasion will give rise
to organized structure. Admittedly, this hypothetical con-
clusion may stretch data interpretation a little too far, but
it could nonetheless stimulate appropriate experimenta-
tion for testing its validity. The attractiveness of this hy-
pothesis is that it may offer some mechanistic underpin-
ning to the process of cancer invasion.
The stakes in MMP research are high because of their
involvement in human pathology, e.g., cancer invasion,
metastasis, or tissue degenerative diseases, (Matrisian,
 
1992; Stetler-Stevenson et al., 1993). There have been sub-
stantial investments in identifying drug targets based on
our knowledge of soluble MMPs (Nelson et al., 2000). The
payoff, though, is still below expectations. Inhibitors of
MMPs are being taken all the way to Phase III clinical tri-
als, e.g., for cancer treatment. Not all results are in yet, but
thus far outcomes are less than spectacular (Yip et al.,
1999). In hindsight, was too much being asked of the solu-
ble MMPs? Perhaps. In fairness, though, soluble MMPs
used to be the only game in town and, being secreted, their
expression, handling, and characterization is easier than
membrane-bound proteins. The membrane-anchored
forms of MMPs, of which MT1-MMP is the best known,
are late arrivals. Furthermore, the fact that MT1-MMP
physiologically activates MMP2 (a soluble collagenase),
might have distracted investigators from looking at it as an
MMP in its own right (Sato et al., 1994). For instance, sub-
strates for MT1-MMP are not well understood. There had
been signs in the field that some fresh looks were nec-
essary, and the Hotary et al. (2000) paper may crystallize
this mood, signaling a shift in focus towards membrane-
anchored MMPs and providing impetus for new experi-
mental frameworks.
A major challenge facing us remains: How do MMPs op-
erate? The matrix surrounding the cells, of which col-
lagens tend to be a dominant component, is often thought
of as a physical barrier constraining movement. MMPs,
several of which show collagenolytic activity, can degrade
the matrix, creating openings. A long-standing view main-
tains that matrix degradation should be enough to form
such openings, but not too much so as to reduce traction.
Such a view is easily accepted because it is rooted in hu-
man experience in the macroscopic world: ever got your
car stuck in mud (SUV owners need not reply)? On the
other hand, traction may take on a whole different mean-
ing on the scale at which cells operate. Efforts to quantify
the mechanical properties of extracellular matrices should
help define whether or not a substrate is permissive for mi-
gration, and one should be prepared for surprises. After
all, overexpression of MT1-MMP disrupts tubulogenesis,
Figure 1. Schematic representation of a proposed correlation be-
tween expression of membrane-anchored MMPs (MT-MMPs),
invasion, and tubulogenesis (drawing by N. Koshikawa, based on
results published in this issue by Hotary et al., 2000).
 
Table I. The Matrix Metalloproteinase Family
 
MMP
number Common name Substrate
 
Secreted 1 Interstitial collagenase Collagens
2 Gelatinase A Gelatin, collagens, laminin-5
3 Stromelysin 1 Collagens, laminin-1, fibronectin
7 Matrilysin Gelatin, fibronectin, laminin-1
8 Neutrophil collagenase Collagens
9 Gelatinase B Gelatin, collagens
10 Stromelysin 2 Collagens, laminin-1, fibronectin
11 Stromelysin 3 Alpha-1–antiproteinase
12 Macrophage elastase Elastin
13 Collagenase 3 Collagens
18 Collagenase 4 ?
19 None ?
20 Enamelysin ?
Membrane anchored 14 MT1-MMP Pro-MMP2, gelatin, collagens, laminin-5
15 MT2-MMP Pro-MMP2, gelatin
16 MT3-MMP Pro-MMP2, collagens
17 MT4-MMP TNF-
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but enhances invasion (Fig. 1). Thus, proteinases may af-
fect cell detachment, cell–cell adhesion, receptor-matrix
interactions, or, perhaps, the way cells perceive surround-
ing matrix (Giannelli et al., 1997; Koshikawa et al., 2000;
Pozzi et al., 2000), in addition to removing mechanical bar-
riers.
An intriguing result of Hotary et al. (2000) is that alter-
ing a topogenic signal had no effect on the ability of MT1-
MMP to disrupt tubulogenesis, suggesting that its delivery
by intracellular transport mechanisms to precise locations
on the cell surface does not matter much. One cannot dis-
count the possibility that MMPs wandering across the
plasma membrane are recruited to hot spots of activity by
polarized receptors (Brooks et al., 1996). More radically,
though, we might have to revisit the well-rooted concept
that, for effectiveness, proteinases must be concentrated at
the leading edge of invading cells. Again, this concept de-
rives its popularity more from an anthropomorphic view
of how a moving cell should be engineered, than from hard
data. An alternative view could be that proteolysis of the
close pericellular matrix, whether or not focused at a hot
spot, sets in motion morphogenetic programs. Maintaining
an open mind (Werb, 1997) and looking for informative
model systems should be a high priority.
Having made all of these considerations, it is still sur-
prising that, in the Hotary experiments, none of the seven
soluble MMPs had any effect on tubulogenesis in collagen
gels, particularly since most of these MMPs are well char-
acterized collagenases (Table I). Could it be that soluble
MMPs, stimulated by SF/HGF, were already at a maxi-
mum in that system, so that no further disruptive effects
were detectable upon overexpression? This is possible but
unlikely, because the disruptive effects on tubulogenesis of
MT1-MMP overexpression required membrane anchor-
ing, seemingly regardless of expression levels. Could it be
that soluble MMPs are generally not included in morpho-
genetic programs because of their lack of spatial specific-
ity? Time will tell, though the available knockouts of two
major collagenases, MMP2 and MMP9, would already
suggest that their participation in morphogenesis is not es-
sential. Thus, MMP2 deficient mice display minor growth
retardation, but appear to develop normally otherwise
(Itoh et al., 1998). In MMP9 deficient mice, vasculariza-
tion of growth plates causes skeletal defects eventually
overcome after birth by compensation (Vu et al., 1998).
In summary, to identify which MMPs are important in
matrix invasion, Hotary et al. (2000) took the direct route:
express them one at a time in informative, albeit complex,
cell model system, and see what happens. The difficulty of
this approach lays not in its conception, but rather in com-
mitting to its elaborate execution. Hence, the considerable
lag from the time reagents first became available to the
time one laboratory produced the experimental data. In
retrospect, what was required was the blending of several
distinct skills in one place, and an effort thorough enough
to allow for meaningful side by side comparisons. The
study reported in this issue (Hotary et al., 2000) did just
that, and the reward is an insight that, though glimpsed
at by others, remained unproven: membrane-anchored
 
MMPs, the MT-MMPs, play a primary role in cellular in-
vasion of collagenous matrices and, at the right levels of
expression, may promote tubulogenesis. Final answer?
Yes, in this system, based on the thoroughness of the Ho-
tary study and the permutations they tested. For generali-
zation or textbooks status, this conclusion is definitely one
to be reckoned with and to be falsified, in a popperian
sense, using other in vitro, and more importantly in vivo
systems. Along this road, no doubt, the cell biology of
MMPs holds in reserve many surprises for us.
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